chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left Arm pit and into the breast very tender; Left Arm pit and into the breast swollen; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ew0150), via an unspecified route of administration in the left arm on 01Apr2021 at 12:45 (at the age of 53-year-old), as a single dose for COVID-19 immunisation. Medical history included weight loss and the patient did not have any allergies to medications, food or other products. Concomitant medications included unspecified allergy injections and global camellia sinensis (GREEN TEA) for weight loss from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: en6207), via an unspecified route of administration in the left arm on 11Mar2021 at 12:45 (at the age of 53-year-old), as a single dose for COVID-19 immunisation. On 04Apr2021, the patient experienced left arm pit and into the breast very tender and swollen for about 3 days after shot. The patient also reported that the tenderness did not show up until 3 days after shot and lasted for about 3 days. No therapeutic measures were taken as the result of adverse events. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events left arm pit and into the breast very tender and swollen was recovered on an unknown date in Apr2021.    No follow-up attempts are needed. No further information is expected.
Hives-entire body, face/hands-swollen, no trouble breathing. All symptoms began morning after IM. Medrol dose pak, epi pen, ZYRTEC, Rx given.
Within 1 hour of injection began to have flu like symptoms. Symptoms persisted over several weeks time. Was tested for flu and covid multiple times with negative results. Flu like symptoms persist and worsen.  Begins to have shortness of breath and loss of apatite. January 30th began having bouts of vomiting. Unable to go to work on January 31.  Feb 6 visit Urgent Care again test negative for Flu and Covid. Was prescribed Pantoprazole SOD DR 40 mg and Ondansetron HCL 4 mg  for nausea and vomiting. February 7 had difficulty breathing-taken to Emergency Room at Medical Center. Tested negative for covid. Had internal bleeding and bleeding into lungs. Ventilated and admitted to ICU from February 7- February 11.
Pt reported to clinic with swelling of injection site, warmth and erythema with minor TTP. LROM of shoulder, no SOB, no CP, no MS changes.
Atrial Fibrillation with sustained heart rate of 180-220 treated with cardioversion
About 18 hours after his PNEUMOVAX he had blurry vision. He has macular eye disease at baseline but it got acutely worse.
It was reported that a pt experienced a red, swollen arm around the injection site after receiving a Tripedia vaccination. The vaccine was identified as Infanrix however the lot number provided is that for Tripedia. it was reported this AE and was not provided with complete details. Reportedly, the Dr is using a smaller gauge needle (smaller than 5/8 needle). No further information was reported. It was not reported whether the pt recovered.
Patient's mother called 9/1/06 at 9:12 am and stated injection site red, swollen, and bigger than 50 cents piece using TYLENOL for low grade temperature.  Also using cold compress.  Patient seen in office on 09/1/06 at 9:40 with redness and swelling of right anterior thigh.  Patient prescribed ATARAX 10 mg/5ml, 1/4 teaspoon four times a day and follow up as needed.
On 08/29/2000 the patient experienced a fever and pain the leg for 3 days. The patient was seen by a physician. Follow up was received from a physician. On approximately 09/12/2000 the patient experienced a nonvesicular rash. It was also reported the patient's brother experience an unspecified adverse event after each does of diphtheria toxoid + pertussis vaccine + tetanus toxoid vaccine. No further information is available.
On May 7th 2008 I got a shot to prevent getting the shingles. Not sure at this time if I'm running into an adverse reaction or not from the shot. Toward the end of January about the 29th 2012. I started having some pain in the posterior upper "L" arm area which I thought might be due to lifting something improperly. On the morning of Saturday Feb 4th I broke out with a red blotch on middle of "L" chest area and one red blotch on "L" back area and 4 red blotches on inner lower left arm area. Left chest and left arm area achy and I felt very tired. On Feb 5th Sunday rash like area appeared on upper inner "L" arm area and small area on left palm area. I was out of town at the time and on return Feb 7th Tuesday I was back and able to see my primary Dr now. Dr diagnosed my problem as shingles. Have had pain and limited use of "L" arm & hand ever since. At the present time I'm using over the counter medication Acetaminophen 250mg, Aspirin 250mg & caffeine 65mg. So far I've gone for acupuncture 12 times to help relieve the swelling and pain. I'm wondering at this time if I would have been better off not getting the preventative shingle shot. The nerve pain is absolutely unbelievable.
Severe headache started almost immediately after injection, followed by numbness down arm of injection and nausea and lack of appetite.  Several hours after injection body aches and extreme fatigue.  12 hours after injection restlessness, chills, sweats, body shaking that lasted for an hour.    Severe headache and pain at injection site lasted over 48 hours.  Started with 800mg ibuprofen almost immediately after injection and onset of headache, and then continued to alternate 1000mg acetaminophen and 800mg ibuprofen for 48 hours after injection.
Developed Bacterial Cellulitis that spread over arm and shoulder for 7 days.    NOTE:  THIRD TIME A VACCINE HAS GIVEN THIS CHILD BACTERIAL CELLULITIS THAT REQUIRED ADDITIONAL DRUGS AND PHYSICIAN CARE.
Information has been received from a medical assistant concerning two patients that on an unspecified dates were vaccinated with a dose of PNEUMOVAX (Lot : 662746/0625Y).  On unspecified dates the patients experienced fever, vomiting, and were not feeling well.  They also had an injection site reaction.  At the time of reporting on 20-AUG-2009, the patient's outcomes were unknown.  Additional information was received from the medical assistant who clarified the previous report, only one unspecified patient was vaccinated with a dose of PNEUMOVAX (Lot : 662746/0625Y).  Follow-up information has been received from a physician concerning an 81 year old female patient who on 14-AUG-2009 was vaccinated in the left deltoid with a dose of PNEUMOVAX (Lot number 662842/1296X (previously reported as lot number 662746/0625Y)).  On 15-AUG-2009 the patient experienced fever (102 degrees F) with chills and body aches.  At the time of the report the patient had recovered from fever, chills and body aches.  A standard lot check investigation has been finalized.  All in-process quality checks for the lot number in question were satisfactory.  The lot met the requirements of the Center for Biologics Evaluation and Research and was released.  This is one of several reports received from the same source.  No further information is available.
positive for Covid19; positive for Covid19; fever; lost his sense of taste and smell; lost his sense of taste and smell; This is a spontaneous report from a contactable consumer.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: not reported), dose 1 via an unspecified route of administration on an unspecified date as a single dose and dose 2 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On 28Jul2021, the patient tested positive for Covid19, has a low grade fever, lost his sense of taste and smell. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 28Jul2021. The outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patient was asking about what happens if the Moderna Covid-19 was given after the expiration date; Circumstance or information capable of leading to medication error; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was asking about what happens if the Moderna Covid-19 was given after the expiration date), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was asking about what happens if the Moderna Covid-19 was given after the expiration date), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was asking about what happens if the Moderna Covid-19 was given after the expiration date), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient was asking about what happens if the Moderna Covid-19 was given after the expiration date) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error).    No concomitant medication were reported. No treatment information was provided by the reporter.   Reporter did not allow further contact
About 1 min after injection the pt became pale and clammy. He started sweating. His heart rate dropped and he said he felt like he was going to pass out. 911 was called.
SHINGLES after Covid vaccine 3/18/2021, Stellara injection 3/21/2021
Feeling anxious; Dizziness; This is a spontaneous report from a contactable pharmacist. A 38-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an intramuscular route of administration on 12Feb2021 at 14:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included anxiety disorder (Anxiety DO), post-traumatic stress disorder (PTSD), pre-diabetes (Pre-DM), penicillin allergy (PCN allergy) and shellfish allergy. It was unknown whether the patient was pregnant at the time of this report. It was unknown whether the patient was diagnosed with COVID-19 prior to the vaccination. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT) and metformin (MANUFACTURER UNKNOWN); both for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in on an unknown date as a single dose for COVID-19 immunisation. On 12Feb2021, at 14:15, the patient experienced feeling anxious approximately 15 minutes after vaccine and dizziness. On 12Feb2021 at 14:15, the patient underwent lab test and procedures, vital signs included blood pressure (bp) was found to be 150/90 (unspecified units), heart rate (HR) was found to be 106 (unspecified units), respiratory rate (RR) was found to be 20 (unspecified units) and arterial oxygen saturation (SaO2 on radial artery) was found to be 95 percent. The patient was monitored and given water in first aid station and assessed by emergency medical technician (EMT) on duty and physician on duty. On the same day at 14:20, the patient had vital signs included blood pressure was found to be 150/90 (unspecified units), heart rate was found to be 86 (unspecified units), respiratory rate was found to be 20 (unspecified units) and arterial oxygen saturation was found to be 95 percent and capillary blood glucose (CBG) was found to be 204 (unspecified units), the patient had vital signs stable and alert and oriented to person, place and time. On the same day at 14:25 the patient was cleared to go home by physician on duty. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. It was unknown whether the patient had been tested for COVID-19 since the vaccination. The clinical outcome of the events feeling anxious and dizziness was resolved on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Patient has a seizure history.  Mother stated they have had numerous vaccines in the past without a problem though.  Patient was waiting the period of time afterwards.  Mother then stated she was having a reaction.  Mother stated she is a nurse and said she believed the patient was having a seizure.  Mother later was not sure if patient had fainted also since she was nervous about receiving the shot in the first place.  After paramedics arrived, they took her glucose and was 77.  Paramedics let mom then take patient home to get food.
This spontaneous report was received from a medical assistant refers to an unknown number of patients of unknown age and gender. On an unknown date the patients were vaccinated with an improperly stored PNEUMOVAX 23 (dose, lot # and route of administration were not reported). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
On 12/21/04 pt was provided with Vivotif Typhoid caps and written instructions on administration for travel. On 12/23/04 provider received t/c from pt describing an "itching reaction" to upper R chest 24 hours after taking dose #1 on 12/21/04. No redness or rash reported, denied dyspnea or itching to back, throat. Referred to MD before continuing on Vivotif. On 12/28/04 provider made T/C to pt; pt advised that he continued taking Vivotif caps Q48 hours without contacting MD, took dose #4 that AM and that itching remained unchanged with no new symptoms.
Subsequent to receiving vax, the pt developed stinging at the injection sit. The pt sough unspecified medical attention. Additional information has been requested.
ADMINISTERED MENACTRA, TRUMENBA, GARDASIL 9, AND HAVRIX VACCINES. APPROXIMATELY 5 MINUTES AFTER ADMINISTRATION, CLIENT STATED SHE FELT DIZZY WITH BLURRED VISION AND DIFFICULTY HEARING. DENIED NAUSEA. GIVEN SOME JUICE TO SIP ON AND COOL PACK APPLIED TO BACK OF NECK. CONTINUED TO COMPLAIN OF DIZZINESS. ASSISTED TO COT AND PLACED IN SUPINE POSITION WITH KNEES ELEVATED AFTER APPROXIMATELY 5 MINUTES, STATED SHE FELT BETTER AND DIZZINESS WAS IMPROVED. ASSISTED TO SIT ON SIDE OF COT FOR APPROXIMATELY 1 TO 2 MINUTES, THEN ASSISTED TO SIT IN CHAIR. AFTER APPROXIMATELY 2 TO 3 MINUTES, ASSISTED TO WAITING ROOM. WAITED WITH DAD FOR APPROXIMATELY 5 MORE MINUTES WITHOUT FURTHER INCIDENT. LEFT IN CARE OF FATHER.
Tested positive for COVID-19; Tested positive for COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 15 month-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 08Dec2021 07:00 (Lot number: FK5127) at the age of 14 months as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Ibuprofen, reaction(s): "Known allergies: Ibuprofen". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 31Dec2021, outcome "recovering" and all described as "Tested positive for COVID-19"; PYREXIA (non-serious) with onset 26Dec2021, outcome "recovering", described as "fever of 101.2"; COUGH (non-serious) with onset 26Dec2021, outcome "recovering", described as "coughing". The patient underwent the following laboratory tests and procedures: body temperature: (26Dec2021) 101.2; sars-cov-2 test: (31Dec2021) positive. Therapeutic measures were taken as a result of drug ineffective, covid-19, pyrexia, cough.  No follow-up attempts are possible. No further information is expected.
Nurse accidentally administered 2 vials after 10 days after expiry to 18 patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Nurse accidentally administered 2 vials after 10 days after expiry to 18 patients) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Nurse accidentally administered 2 vials after 10 days after expiry to 18 patients). In October 2021, EXPIRED PRODUCT ADMINISTERED (Nurse accidentally administered 2 vials after 10 days after expiry to 18 patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.  The dates of administration of vaccine are 15-Oct-2021 to 8 or 9 patient and 18-Oct-2021 to 8 or 9 patient.
I had a really horrible bruise. It was the blackest bruise I've seen, very deep and very painful. Silver dollar size or slightly larger. It has been 3 months, and the mark is still there. It's faded a lot, but there's still an obvious yellow mark.   Could be related to the needle itself, but since I haven't heard of anyone else having this, I wanted to make sure to share this info.   I did not have a bruise or much pain at all with the second shot.
Early in the morning of January 9th, 2021, the day after receiving my first injection, I woke up in bed with extreme soreness and moderate swelling at the injection site. On a scale from one to ten, the level of discomfort was seven or eight. I had expected at least some soreness as I normally have soreness after receiving flu shots and other injections. However, I was very surprised as to how sore my arm really was. Fortunately, when I woke up the next day, January 10th, the pain had mostly subsided, with just a little swelling evident at the injection site.
Tested positive for Covid; Really bad headache; Shooting pain; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer sales representative.  A 72-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# not provided), via an unspecified route of administration on 26Jan2021 at SINGLE DOSE for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had really bad headache with shooting pain exactly one week after COVID vaccine (noted on 02Feb2021). The patient also tested positive for COVID one week later on 03Feb2021. Outcome of the events were unknown.   No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details: Patient received pediatric pfizer vaccine and had slight dizziness then recovered. Could not hold down water and threw up. 911 called and fire department showed up and examined patient to be fine. Father was present all this while with patient.
Patient experienced redness and stiffness of the skin surrounding the injection site (radius 0.5-1 in). It also warm to touch. Patient was unsure if it was getting better or worse at the time she initially report the reaction (9/27/19). Asked patient to keep and eye on it to make sure it's not getting worse. If it becomes more painful or the redness surrounding the site expands in size, advised patient to seek care at walk in clinic or with provider. In addition advised patient she may take Tylenol and apply cold pack/ice to injection site to help with the pain. Did not have any symptoms of achiness, malaise, etc. Only pain at site.
I had swelling at the injection site. Then saturday, i started itching a welp which was on the opposite arm of the injection site. I started feeling like I had a bite, or i was bitten by something, an ant or mosquito. I was in a weird part of my arm. I went to a movie t about noon, and all down my arm and down the side of my back started to itch. At that point, I was sitting next to someone, nothing weird about that. When I got home, it started to spread down the back of my leg, my butt cheek and down my thigh, it spread over to the other leg in the same area. and by evening, it went to my calves. So I took benadryl to go to sleep, cause it was unbareable. I didnt really know what hives were, so I looked it up. Woke up on Sunday morning, it was activated all over everywhere. I couldnt take benadryl , so i went and brought allegra and I took that. By the time I took that, it had gotten so much worst. In my feet, between my toes, my palms, my face, I can feel my tongue get a little thick. I started to get nervous. By then I had already taken allegra, soon as it kicked in, it went away. This morning, it was worst. I was welted everywhere, but my torso is not welted.
Approx 14:00 MMR administered sq approx 14:10 redness, itching,  feeling of swelling in throat. Went to WRRH Clinic approx 14:15 after epi pen and benadryl. At clinic recieved epi, IM benadryl and IM decadrol without improvement sent to white co. ER
Individual states vaccination was given and later that same day, her arm began to itch.  It was swollen, red, and warm to touch at the sight where varicella injection was given. She denies difficulty breathing, swallowing, numbness of tingling.  She did not seek medical advice from a physician at time of reaction.  She denies taking Benadryl or providing any treatment for the itching/redness/swelling.
Pt recvd vax & exp a hot streak on arm & neck, difficulty breathing, numbness, hypertension, an asthmatic type cough sx were treated w/Epi; pt was reported to be very sick for the 1st wk to 10 days p/2nd dose;